Mr Sheng Qiu is a Consultant Colorectal and General Surgeon with a special interest in advanced and complex colorectal cancer. Mr Qiu has experience in pelvic exenteration surgery for locally advanced and recurrent rectal cancers. He also works with liver surgeons performing simultaneous bowel and liver resections, treating patients with metastatic colorectal cancer. Mr Qiu's research interests include novel biomarkers in cancer, personalisation of cancer treatment, and the consequences of colorectal cancer treatment. Read his full profile: https://bit.ly/3U3Lo58 #LikeNoOther #BowelCancerAwarenessMonth
The Royal Marsden - Private Care’s Post
More Relevant Posts
-
Cancer research is critical, especially when it comes to pancreatic cancer. When surgery is not recommended for a patient with pancreatic cancer, radiation therapy is used to control the disease. The goal of Dr. Nichols' clinical trial is to determine if proton radiation combined with chemotherapy can better control a pancreatic cancer patient's disease so that surgery is then possible. Find out about this clinical trial for pancreatic cancer: https://bit.ly/4ewpLS1 #pancreaticcancer #pancreascancer #PancreaticCancerAwarenessMonth Pancreatic Cancer Action Network #protontherapy #beatcancer
To view or add a comment, sign in
-
October is Liver Cancer Awareness Month! To mark this occasion, we are happy to share insights from Dr. Roberto Luigi Cazzato, Chairperson of CIRSE’s Research Committee and Coordinating Investigator of BOREALIS, the new CIRSE-sponsored registry in bone metastases. “Interventional radiology is a key player in the management of liver cancers with treatments such as ablation and radioembolization that are changing treatment paradigms for patients with liver cancer. In particular, radioembolization has added new therapeutic alternatives to patients with locally advanced liver tumours and percutaneous ablation has shown results that may be even better than those obtained by surgery (better local tumour control, shorter hospital stays and less complications), at least for small-sized CRLM (< 3 cm), as highlighted by the COLLISION trial. Next Research is highly involved in these two fields with multiple studies such as CIRT and CIEMAR.” Explore our studies and publications 👉 https://lnkd.in/eiUmbYgA #LiverCancerAwarenessMonth #InterventionalRadiology #Research #LiverCancer
To view or add a comment, sign in
-
🔬 Adjuvant Chemotherapy for Stage II Colon Cancer: A Critical Review 🔬 1.0 #CME 📚 Authors: Sara Elena Rebuzzi, Guido Pesola, Valentino Martelli, Alberto Felice Sobrero In the management of stage II colon cancer, surgery alone has a high cure rate of about 80%, but the role of adjuvant chemotherapy remains debated, especially for patients with high-risk features like T4 tumors or insufficient nodal sampling. This study provides: A thorough review of existing trials on risk stratification and the therapeutic benefits of adjuvant chemotherapy. Quantification of the impact of various prognostic factors. A proposed decision algorithm to help guide clinical practice. 🔗 https://lnkd.in/dNu4jBxz #PhysicianInsights #MedicalPractice #ColonCancer #Oncology #MedicalResearch #CME #DoctorsUpdate
To view or add a comment, sign in
-
Hello LinkedIn community Brain cancer is a serious condition characterized by the uncontrolled growth of cells within the brain. It can originate in the brain (primary brain cancer) or spread from other parts of the body (secondary, or metastatic, brain cancer). Primary brain tumors can be benign (non-cancerous) or malignant (cancerous), with gliomas and meningiomas being among the most common types. Symptoms of brain cancer vary depending on the tumor's size, location, and rate of growth and may include headaches, seizures, cognitive or personality changes, and motor skill impairments. Diagnosis typically involves imaging studies such as MRI or CT scans, and treatment options include surgery, radiation therapy, and chemotherapy. Advances in medical research are continuously improving the understanding and management of brain cancer, offering hope for better outcomes for patients. #snsinstitutions #snsdesignthinker #designthinking
To view or add a comment, sign in
-
Metastatic cancer is responsible for the majority of cancer-related deaths since surgery and subsequent radio- or chemotherapy often fail to remove all cancer cells. In addition, metastases frequently develop immunosuppressive resistance mechanisms protecting them from immunotherapy that work well in primary tumors. Researchers at Technische Universität München developed cells to be used in NK-or T-cell based therapies that overcome the immunosuppressive tumor microenvironment and thus retain their full cytotoxic activity. To read more click here: https://lnkd.in/ddSNnbT9
To view or add a comment, sign in
-
August 1 is #WorldLungCancerDay. The American Cancer Society predicts that there will be more than 100,000 deaths from #LungCancer this year. When lung cancer is found at an earlier stage before it spreads, it’s more likely to be treated successfully. That’s why it’s so important that more individuals get screened – even if they may not be experiencing symptoms. At On Target, we’re committed to helping patients and doctors fight this disease. Our targeted intraoperative molecular imaging agent helps surgeons visualize early-stage lung cancer, remove more cancer during surgery, and contributes to a world with better #LungHealth. #WLCD24 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
To view or add a comment, sign in
-
📍 Live from the Canadian Surgery Forum in Winnipeg! We’re here at #CSF2024, sharing how Progress CONNECT can support surgeons in having thoughtful discussions with their breast cancer patients. Research shows that there are over 50 types of breast cancer. Progress CONNECT, designed by Breast Cancer Canada, is an online tool that provides patients with information specific to their type. By answering a series of questions using their pathology results, patients receive a personalized report outlining their breast cancer type and potential treatment options based on stage and biomarker status. The goal? To help patients have meaningful, informed discussions with their oncologists, supported by evidence-based information relevant to their stage and biomarkers. Please visit: progressconnect.ca **Reports are for informational purposes only and are not intended to replace medical advice. Breast Cancer Canada encourages informed, collaborative decision-making between patients and their oncology teams. #progressCONNECT #breastcancerresearch
To view or add a comment, sign in
-
New review from The #FASEBJournal: Targeting KRAS in gynecological malignancies Cervical, endometrial, and ovarian cancers are among the most common gynecological malignancies and while surgery, chemotherapy, and radiotherapy are standard treatments, challenges like relapse and drug resistance persist. KRAS, one of the most frequently mutated oncogenes, plays a pivotal role in these cancers. This comprehensive review explores how KRAS serves as a biomarker and outlines emerging therapeutic strategies targeting the KRAS pathway in gynecological tumors. 📄 Read the full article to dive deeper into potential breakthroughs in cancer treatment: https://hubs.ly/Q02YcdP00 #CancerResearch #GynecologicalCancer #KRAS #Oncology #MedicalResearch #CancerTreatment #FASEB
To view or add a comment, sign in
-
Understanding sarcoma treatment options involves considering the type, location, stage, and spread of the cancer. Treatment typically includes surgery to remove the tumor, often sparing the limb in osteosarcoma cases. Radiation can shrink the tumor before surgery or eliminate remaining cancer cells afterward, and may serve as the primary treatment if surgery isn't feasible. Chemotherapy, using drugs to treat cancer, is particularly effective when the cancer has spread and can be combined with or used instead of surgery. Targeted therapies, which use drugs or synthetic antibodies to block cancer cell growth while leaving normal cells unharmed, represent a newer approach. Knowing these options allows for a tailored treatment plan, offering hope and precision in the fight against sarcoma. To book an appointment, call 040 6810 6527 or visit www.carehospitals.com #CAREHospitals #TransformingHealthcare #SarcomaTreatment #CancerCare #Oncology #CancerTreatment #FightSarcoma #HealthAndWellness #CancerAwareness
To view or add a comment, sign in
-
🫁 How Do Colorectal Cancer Cells Spread to the Lungs? 🧬 In this video, we’re diving into the pathways of how colorectal cancer metastasizes to the lungs. 🔬💡 From the bloodstream to the lymphatic system, we’ll explore the routes cancer takes to reach the lungs, why this happens, and what it means for patients. 🚶♂️ Stay tuned as we uncover the complexities behind metastatic dissemination and what this process looks like inside the body. 🌿 Hit that like button, share with others, and subscribe for more insights into thoracic surgery and oncology! 🩺✨ #CancerSpread #MetastasisExplained #ColorectalCancer #LungMetastasis #ThoracicSurgery #OncologyEducation #CancerPathways #MedicalLearning #SurgeonsInsight #CancerResearch #MedicalEducation #LymphaticSystem #Bloodstream #CancerJourney #StayInformed
To view or add a comment, sign in
1,788 followers